Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
24.08
-0.72 (-2.90%)
At close: Mar 6, 2026, 4:00 PM EST
24.08
0.00 (0.00%)
After-hours: Mar 6, 2026, 4:06 PM EST
Zymeworks Employees
Zymeworks had 264 employees as of December 31, 2025. The number of employees decreased by 22 or -7.69% compared to the previous year.
Employees
264
Change (1Y)
-22
Growth (1Y)
-7.69%
Revenue / Employee
$401,383
Profits / Employee
-$307,311
Market Cap
1.77B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Recursion Pharmaceuticals | 800 |
| Vericel | 357 |
| Syndax Pharmaceuticals | 298 |
| Relay Therapeutics | 192 |
| Olema Pharmaceuticals | 122 |
| Definium Therapeutics | 106 |
| Enliven Therapeutics | 65 |
ZYME News
- 2 days ago - Zymeworks FY25 Review: From Milestone Volatility To 2026 Upside - Seeking Alpha
- 3 days ago - Zymeworks Inc. (ZYME) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing - GlobeNewsWire
- 4 days ago - Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 22 days ago - Zymeworks To Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 2, 2026 - GlobeNewsWire
- 5 weeks ago - Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Zymeworks Inc. (ZYME) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy - GlobeNewsWire